16hon MSN
Eli Lilly CEO David Ricks on Q4 results: We're the market leader in both diabetes and obesity now
Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the weight-loss ...
Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the weight-loss drug market, drug pipeline, 2026 outlook, and more.
Eli Lilly CEO David Ricks says AI helps him stay up to date on the latest science. Ricks said OpenAI's ChatGPT is "too verbal" for those types of queries. He wants something that is "more terse" and ...
It’s hard for a major pharmaceutical company to launch one successful novel drug on the market, but Dave Ricks, CEO of Eli Lilly, could potentially be overseeing two—in obesity and Alzheimer’s, both ...
Hosted on MSN
Lilly raises 2025 revenue guidance to $63–$63.5B with 54% Q3 growth and major pipeline advances
Earnings Call Insights: Eli Lilly and Company (LLY) Q3 2025 David Ricks, Chairman, CEO & President, opened the call stating, "Q3 was another strong quarter for Lilly. We made progress across all our ...
Eli Lilly CEO David Ricks, left, and Pennsylvania Gov. Josh Shapiro at a Lehigh County event on Jan. 30, 2026. Eli Lilly will ...
David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower the cost of Novo Nordisk's Wegovy and Eli Lilly's Zepbound. Ricks said ...
Eli Lilly chairman and CEO David Ricks joins 'Squawk on the Street' to discuss the path to becoming a trillion dollar company, launch of its obesity pill, new innovation at the company, drug pipeline ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Brent D. Griffiths Every time Brent D. Griffiths publishes a story, you’ll get an alert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results